Nu Skin Enterprises Inc. (NUS)
NUS trades on NYSE in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$5.01
+2.88% on the day
Market cap
$243.9M
Micro cap
Revenue · 2025
$1.5B
-14.3% on 2024
Net income · 2025
$160.2M
10.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NUS on NYSE |
| Sector | Health Care |
| Industry | Other Pharmaceuticals |
| Country | United States |
| IPO year | 1996 |
| SEC CIK | 0001021561 |
| SEC industry code | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.5B |
| Net income | $160.2M |
| Operating income | $65.8M |
| Net margin | 10.8% |
| Operating margin | 4.4% |
| Revenue growth | -14.3% |
| Cash | $238.6M |
| Total assets | $1.4B |
| P/E (computed) | 1.5× |
| P/S (computed) | 0.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3ASR | S-3ASR | 2018-03-01 |
| Latest annual report FORM 10-K | 10-K | 2026-02-13 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-08-21 |
| Latest proxy 2026 NOTICE OF INTERNET AVAILABILITY | DEFA14A | 2026-04-03 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Other Pharmaceuticals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ZSTK | ZeroStack Corp. | $4.37 | 0.00% | $95.4M |
| ESYN | EnerSyn Global Inc. | $2.03 | +3.57% | $60.3M |
| HLF | Herbalife Ltd. Common Shares | $14.21 | +4.41% | $1.5B |
| COSM | Cosmos Health Inc. | $0.3829 | +9.53% | $38.5M |
| MEDS | DataMeds AI Inc. | $3.03 | -1.30% | $13.7M |
| HKPD | Cellyan Biotechnology Co. Ltd | $0.1049 | -1.59% | $5.1M |
| CAH | Cardinal Health Inc. | $239.72 | +0.69% | $55.5B |
| COR | Cencora Inc. | $330.11 | +1.55% | $63.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier